# Women's Health Sector Canonical URL: https://biopharmsignal.com/sector/women-s-health Women's Health is a company sector tag on BioPharmSignal. This page groups public biotech and healthcare companies associated with Women's Health, making it easier to scan related businesses, compare peers, and follow companies exposed to the same modality, disease area, or development theme. Companies currently grouped under Women's Health: 14 ## Recent Sector News - 2026-07-09 20:05 EST — SERA — [PRIME SUBGROUP ANALYSIS DEMONSTRATES 22% REDUCTION IN NICU ADMISSIONS IN FIRST-TIME PREGNANCIES USING PreTRM® Test-GUIDED CARE](https://biopharmsignal.com/news/SERA/prime-subgroup-analysis-demonstrates-22-reduction-in-nicu-admissions-in-first-ti-1eec527c) — Source: Sera Prognostics - 2026-06-30 20:05 EST — SERA — [SERA PROGNOSTICS ANNOUNCES APPOINTMENT OF MARK CAPONE TO ITS BOARD OF DIRECTORS](https://biopharmsignal.com/news/SERA/sera-prognostics-announces-appointment-of-mark-capone-to-its-board-of-directors-8cc61214) — Source: Sera Prognostics - 2026-06-24 20:05 EST — SERA — [SERA PROGNOSTICS COLLABORATES ON ARPA-H AWARD TO ADVANCE POINT-OF-CARE DIAGNOSTIC FOR SAFER BIRTH](https://biopharmsignal.com/news/SERA/sera-prognostics-collaborates-on-arpa-h-award-to-advance-point-of-care-diagnosti-7f391c59) — Source: Sera Prognostics - 2026-06-23 20:05 EST — SERA — [SERA APPLAUDS ILLINOIS INITIATIVE TO EXPAND MEDICAID COVERAGE FOR PROTEOMIC BLOOD TESTING IN PREGNANCY](https://biopharmsignal.com/news/SERA/sera-applauds-illinois-initiative-to-expand-medicaid-coverage-for-proteomic-bloo-969662d4) — Source: Sera Prognostics - 2026-06-01 20:05 EST — SERA — [SERA PROGNOSTICS ANNOUNCES BOARD TRANSITION](https://biopharmsignal.com/news/SERA/sera-prognostics-announces-board-transition) — Source: Sera Prognostics - 2026-05-28 13:04 EST — PGNY — [New Progyny Study Shows Growing Demand for Human Guidance in an Increasingly Digital Healthcare System](https://biopharmsignal.com/news/PGNY/new-progyny-study-shows-growing-demand-for-human-guidance-in-an-increasingly-digital-healthcare-system) — Source: Progyny - 2026-05-26 12:00 EST — PGNY — [Progyny, Inc. Announces Share Repurchase Program](https://biopharmsignal.com/news/PGNY/progyny-inc-announces-share-repurchase-program) — Source: Progyny - 2026-05-12 20:05 EST — TXMD — [TherapeuticsMD Announces First Quarter 2026 Financial Results](https://biopharmsignal.com/news/TXMD/therapeuticsmd-announces-first-quarter-2026-financial-results) — Source: TherapeuticsMD - 2026-05-11 14:57 EST — PGNY — [Progyny, Inc. to Present at BofA Securities 2026 Health Care Conference](https://biopharmsignal.com/news/PGNY/progyny-inc-to-present-at-bofa-securities-2026-health-care-conference) — Source: Progyny - 2026-05-07 20:01 EST — PGNY — [Progyny, Inc. Announces First Quarter 2026 Results](https://biopharmsignal.com/news/PGNY/progyny-inc-announces-first-quarter-2026-results) — Source: Progyny - 2026-05-06 20:05 EST — SERA — [SERA PROGNOSTICS REPORTS FIRST QUARTER 2026 FINANCIAL RESULTS](https://biopharmsignal.com/news/SERA/sera-prognostics-reports-first-quarter-2026-financial-results) — Source: Sera Prognostics - 2026-04-23 17:56 EST — PGNY — [Progyny, Inc. Announces Details for Its First Quarter 2026 Results Report](https://biopharmsignal.com/news/PGNY/progyny-inc-announces-details-for-its-first-quarter-2026-results-report) — Source: Progyny - 2026-04-22 12:05 EST — SERA — [SERA PROGNOSTICS ANNOUNCES CONFERENCE CALL AND WEBCAST OF FIRST QUARTER FISCAL YEAR 2026 FINANCIAL RESULTS ON MAY 6, 2026](https://biopharmsignal.com/news/SERA/sera-prognostics-announces-conference-call-and-webcast-of-first-quarter-fiscal-year-2026-financial-results-on-may-6-2026) — Source: Sera Prognostics - 2026-04-16 13:06 EST — PGNY — [Progyny Expands Access to Fertility and Women’s Health with Industry’s First Fully Insured Supplemental Plan](https://biopharmsignal.com/news/PGNY/progyny-expands-access-to-fertility-and-women-s-health-with-industry-s-first-fully-insured-supplemental-plan) — Source: Progyny - 2026-04-01 13:23 EST — PGNY — [Progyny Commemorates 10 Years of Redefining Women’s Health and Family Building Care](https://biopharmsignal.com/news/PGNY/progyny-commemorates-10-years-of-redefining-women-s-health-and-family-building-care) — Source: Progyny - 2026-03-30 20:05 EST — TXMD — [TherapeuticsMD Announces Full Year 2025 Financial Results](https://biopharmsignal.com/news/TXMD/therapeuticsmd-announces-full-year-2025-financial-results) — Source: TherapeuticsMD - 2026-03-18 20:05 EST — SERA — [SERA PROGNOSTICS REPORTS FOURTH QUARTER AND FULL YEAR 2025 FINANCIAL RESULTS](https://biopharmsignal.com/news/SERA/sera-prognostics-reports-fourth-quarter-and-full-year-2025-financial-results) — Source: Sera Prognostics - 2026-03-06 14:03 EST — PGNY — [Progyny, Inc. Executives to Participate in Upcoming Investor Conferences](https://biopharmsignal.com/news/PGNY/progyny-inc-executives-to-participate-in-upcoming-investor-conferences) — Source: Progyny - 2026-03-04 13:05 EST — SERA — [SERA PROGNOSTICS ANNOUNCES CONFERENCE CALL AND WEBCAST OF FOURTH QUARTER AND FISCAL YEAR 2025 FINANCIAL RESULTS ON MARCH 18, 2026](https://biopharmsignal.com/news/SERA/sera-prognostics-announces-conference-call-and-webcast-of-fourth-quarter-and-fiscal-year-2025-financial-results-on-march-18-2026) — Source: Sera Prognostics - 2026-02-26 21:01 EST — PGNY — [Progyny, Inc. Announces Fourth Quarter 2025 Results](https://biopharmsignal.com/news/PGNY/progyny-inc-announces-fourth-quarter-2025-results) — Source: Progyny ## Companies - [AGRX](https://biopharmsignal.com/company/AGRX) — Agile Therapeutics - [AWH](https://biopharmsignal.com/company/AWH) — Aspira Women's Health - [DARE](https://biopharmsignal.com/company/DARE) — Dare Bioscience, Inc. - [EVFM](https://biopharmsignal.com/company/EVFM) — Evofem Biosciences - [FEMY](https://biopharmsignal.com/company/FEMY) — FEMASYS - [HOLX](https://biopharmsignal.com/company/HOLX) — Hologic - [IVOB](https://biopharmsignal.com/company/IVOB) — INVO BioScience - [UTRS](https://biopharmsignal.com/company/UTRS) — Minerva Surgical - [NTRA](https://biopharmsignal.com/company/NTRA) — Natera - [OBSV](https://biopharmsignal.com/company/OBSV) — ObsEva - [PGNY](https://biopharmsignal.com/company/PGNY) — Progyny - [SERA](https://biopharmsignal.com/company/SERA) — Sera Prognostics - [COO](https://biopharmsignal.com/company/COO) — The Cooper Companies - [TXMD](https://biopharmsignal.com/company/TXMD) — TherapeuticsMD